期刊文献+

硼替佐米治疗滤泡性淋巴瘤的不良反应及护理对策 被引量:8

Adverse reaction and management strategies of Bortezomib for the treatment of patients with follicular lymphoma
下载PDF
导出
摘要 目的总结硼替佐米治疗滤泡性淋巴瘤(Follicular Lymphoma,FL)患者所致不良反应的观察要点及护理措施。方法对我院11例复发难治性FL患者应用硼替佐米进行治疗,针对可能出现的不良反应进行预防性健康指导,密切监测给药进程,出现不良反应后及时给予对症治疗及护理。结果11例患者均行5周期化疗,不良反应除周围神经病变、带状疱疹外主要为中性粒细胞及血小板减少、发热、疲乏、胃肠道反应,中重度不良反应较多。结论硼替佐米治疗滤泡性淋巴瘤患者不良反应虽多,但通过有效治疗及护理,药物毒性可有效控制,患者耐受良好。
出处 《护士进修杂志》 2013年第8期713-715,共3页 Journal of Nurses Training
关键词 硼替佐米 滤泡性淋巴瘤 不良反应 护理 Bortezomib Follicular lymphoma Adverse reaction Nursing
  • 相关文献

参考文献12

二级参考文献60

  • 1Jemal A, Siegel R, Ward E, et al. Cancer statistics 2007. CA Cancer J Clin,2007,57(1) :43-60.
  • 2Sirohi B, Powles R. Multiple myeloma. Lancet, 2004; 363 (9412) :875-887.
  • 3Durie BL, Harousseau JH, Miguel JS, et al. International uniform response criteria for multiple myeloma. Luekemia, 2006 , 20(9) : 1467-1473.
  • 4National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in OneologyTM Multiple Myeloma (V. 3. 2008). Available at http://www. nccn. org/ professionals/physician_gle/PDF/myeloma. pdf.
  • 5Palumbo A, Bringhen S, Caravita T, et al. Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial. Lancet,2006 367(9513) :825-831.
  • 6Adams J. The proteasome: a suitable antineoplastic target. Nat Rev Cancer,2004,4(5) :349-360.
  • 7Hideshima T, Mitsiades C, Akiyama M, et al. Molecular mechanisms mediating antimyeloma activity of proteasomc inhibitor PS-341. Blood, 2003 ,101 (4) : 1530-1534.
  • 8Roccaro AM, Hideshima T, Raje N, et al. Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial ceils. Cancer Res, 2006 , 66 (1) : 184-191.
  • 9Manochakian R, Miller K, Chanan-Khan A. Clinical impact of bortezomib in frontline regimens for patients with multiple myeloma. The Oncologist,2007,12(8) :978-990.
  • 10Mateos MV, Hernandez .IM, Hernandez MT, et al. Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multieenter phase 1/2 study. Blood,2006,108(7):2165-2172.

共引文献58

同被引文献48

引证文献8

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部